Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark S. Levine currently holds 330,230 shares of Flexion Therapeutics Inc (FLXN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark S. Levine has been a net seller of FLXN stock. They have purchased $0 and sold $2.3M worth of shares.
Mark S. Levine's most recent insider trade was on Aug 21, 2024, when they sold 3,164 shares at $31.84 per share.
Mark S. Levine serves as Executive at Flexion Therapeutics Inc (FLXN). They have executed 43 insider transactions totaling $2.3M over their tenure at the company.
Mark S. Levine holds the position of Executive at Flexion Therapeutics Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Mark S. Levine has shown a selling trading pattern, with $0 in total purchases and $2.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark S. Levine was on Nov 19, 2021, when they sold $1.1M worth of FLXN shares. This transaction involved 133,486 shares at $8.50 per share.
Mark S. Levine currently owns 330,230 shares of Flexion Therapeutics Inc (FLXN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark S. Levine's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark S. Levine has 43 Form 4 filings on record as an insider at Flexion Therapeutics Inc.
Set alerts for Mark S. Levine and 40,000+ other insiders.